LIMITED GUARANTEELimited Guarantee • November 23rd, 2020 • Hillhouse Capital Advisors, Ltd. • Biological products, (no disgnostic substances) • New York
This LIMITED GUARANTEE, dated as of November 19, 2020 (this “Limited Guarantee”), is made by Hillhouse Capital Investments Fund IV, L.P., an exempted limited partnership formed under the Laws of the Cayman Islands (the “Guarantor”), in favor of China Biologic Products Holdings, Inc., an exempted company incorporated with limited liability under the Laws of the Cayman Islands (the “Guaranteed Party”). This Limited Guarantee is being delivered to the Guaranteed Party concurrently with the execution and delivery of the Merger Agreement (as defined below). Unless otherwise defined herein, capitalized terms used herein shall have the meanings assigned to them in the Merger Agreement.
subscription agreementSubscription Agreement • September 14th, 2020 • Hillhouse Capital Advisors, Ltd. • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of September 3, 2020, by and between I-Mab, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), Gaoling Fund, L.P., an exempted limited partnership organized under the laws of the Cayman Islands (“Gaoling”), and YHG Investment, L.P., an exempted limited partnership organized under the laws of the Cayman Islands (“YHG” and, together with Gaoling, the “Purchasers” and, each, a “Purchaser”).
AMENDMENT TO SUBSCRIPTION AGREEMENTSubscription Agreement • December 21st, 2020 • Hillhouse Capital Advisors, Ltd. • Pharmaceutical preparations • New York
This written amendment (this “Amendment”), entered into and effective as of December 17, 2020, is made to that Subscription Agreement (the “Subscription Agreement”) by and among Gaoling Fund, L.P., an exempted limited partnership organized under the laws of the Cayman Islands, and YHG Investment, L.P., an exempted limited partnership organized under the laws of the Cayman Islands (collectively, the “Purchasers” and, each, a “Purchaser”) and I-Mab, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”). Purchasers and the Company, each are hereinafter referred to as a “Party” and together the “Parties”. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Subscription Agreement.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • August 18th, 2023 • HHLR Advisors, Ltd. • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • November 14th, 2024 • HHLR Advisors, Ltd. • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
Form of warrantHillhouse Capital Advisors, Ltd. • September 14th, 2020 • Pharmaceutical preparations
THIS CERTIFIES THAT, for value received, [GAOLING FUND, L.P.]/[YHG INVESTMENT, L.P.], or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from I-Mab, a company incorporated under the laws of the Cayman Islands (the “Company”), ordinary shares of the Company, par value of US$0.0001 per share (the “Shares”), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the subscription agreement, dated as of [●], 2020, by and among the Company and the Holder described therein (the “Purchase Agreement”). Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Purchase Agreement. The Holder is subject to certain restrictions s
form of call optionHillhouse Capital Advisors, Ltd. • September 14th, 2020 • Pharmaceutical preparations • New York
This letter (the “Letter”) sets forth terms and conditions in connection with certain call option rights to purchase from the undersigned (collectively, the “Grantors”) certain number of ordinary shares of I-Mab (the “Company”), an exempted company incorporated with limited liability under the laws of the Cayman Islands, par value of US$0.0001 per share (the “Shares”) granted by the Grantors to the Purchasers as follows:
